| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -43.32M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, AVBP returned +44.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +44.7% |
| 1 year | +44.8% |
| All-time high | $34.74 (Jun 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in AVBP would be worth today ›No. ArriVent BioPharma, Inc. has not paid a dividend in the past 12 months.
ArriVent BioPharma, Inc. stock trades on NASDAQ under the ticker symbol AVBP.
ArriVent BioPharma, Inc. is part of the Healthcare sector.
ArriVent BioPharma, Inc. has a market cap of 1.44B USD, based on the latest quote.
ArriVent BioPharma, Inc. is expected to report earnings around Nov 16, 2026. That date is an estimate and has not been confirmed by the company.
